Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Pollack

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The New York Times on the Web|February 3, 2005
Medical researcher moves to sever ties to companiesAndrew Pollack
The New York Times on the Web|September 16, 2006
Stanford to ban drug makers' gifts to doctors, even pensAndrew Pollack
The New York Times on the Web|March 4, 2005
Patients in test won't get drug, Amgen decidesAndrew Pollack
The New York Times on the Web|June 30, 1991
Both heart drugs are effective; doctors prescribe the costly oneAndrew Pollack
The New York Times on the Web|June 12, 2002
Debate on human cloning turns to patentsAndrew Pollack
The New York Times on the Web|October 23, 2004
In drug research, some guinea pigs are now humanAndrew Pollack
The New York Times on the Web|June 22, 2005
Justices expand rights to experiment with patented drugsAndrew Pollack
The New York Times on the Web|February 3, 2005
Patient care vs. corporate connections: Cleveland Clinic wants to change but won't cut ties to industryReed Abelson, Andrew Pollack
The New York Times on the Web|June 7, 2006
Why the data diverge on the dangers of Vioxx: even in medical journals, statistics can be subject to broad interpretationAndrew Pollack, Reed Abelson
The New York Times on the Web|February 1, 2007
F.D.A. tentatively declares food from clones animals to be safe; critics say risks have not been fully weighedAndrew Pollack, Andrew Martin
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The New York Times on the Web|February 3, 2005
Medical researcher moves to sever ties to companiesAndrew Pollack
The New York Times on the Web|September 16, 2006
Stanford to ban drug makers' gifts to doctors, even pensAndrew Pollack
The New York Times on the Web|March 4, 2005
Patients in test won't get drug, Amgen decidesAndrew Pollack
The New York Times on the Web|June 30, 1991
Both heart drugs are effective; doctors prescribe the costly oneAndrew Pollack
The New York Times on the Web|June 12, 2002
Debate on human cloning turns to patentsAndrew Pollack
The New York Times on the Web|October 23, 2004
In drug research, some guinea pigs are now humanAndrew Pollack
The New York Times on the Web|June 22, 2005
Justices expand rights to experiment with patented drugsAndrew Pollack
The New York Times on the Web|February 3, 2005
Patient care vs. corporate connections: Cleveland Clinic wants to change but won't cut ties to industryReed Abelson, Andrew Pollack
The New York Times on the Web|June 7, 2006
Why the data diverge on the dangers of Vioxx: even in medical journals, statistics can be subject to broad interpretationAndrew Pollack, Reed Abelson
The New York Times on the Web|February 1, 2007
F.D.A. tentatively declares food from clones animals to be safe; critics say risks have not been fully weighedAndrew Pollack, Andrew Martin
Pageof 3